← Back to Search

Behavioural Intervention

E-CBSST for Schizophrenia (E-CBSST Trial)

N/A

Waitlist Available

Led By Eric Granholm, PhD

Research Sponsored by University of California, San Diego

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 60 years or older

Willing and able to speak English

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, end of executive function training (week 2), mid-trial (week 11), end-trial (week 20)

Awards & highlights

E-CBSST Trial Summary

This trial aims to test a combination of two types of training, Executive Function Training and Cognitive-Behavioral Skills Training, to see if it is effective in improving social skills. The goal is to

Who is the study for?

This trial is for individuals with schizophrenia, psychosis, or schizoaffective disorder. Participants should be interested in a new therapy that combines cognitive and behavioral skills training with exercises to improve thinking and decision-making.Check my eligibility

What is being tested?

The study tests E-CBSST, which blends Executive Function Training (to enhance thinking and decision-making) with Cognitive-Behavioral Skills Training (for social skills). It aims to see if this can significantly improve daily functioning.See study design

What are the potential side effects?

Since E-CBSST is a non-medical intervention focusing on training and skill development, it may not have typical drug side effects. However, participants might experience fatigue or emotional discomfort during the sessions.

E-CBSST Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 60 years old or older.

Select...

I can speak and understand English.

E-CBSST Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, end of executive function training (week 2), mid-trial (week 11), end-trial (week 20)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, end of executive function training (week 2), mid-trial (week 11), end-trial (week 20)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, end of executive function training (week 2), mid-trial (week 11), end-trial (week 20) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Comprehensive Modules Test

Independent Living Skills Survey

Secondary outcome measures

Birchwood Social Functioning Scale

Clinical Assessment Interview for Negative Symptoms

Cumulative Illness Rating Scale-Geriatric

+7 more

E-CBSST Trial Design

1Treatment groups

Experimental Treatment

Group I: E-CBSSTExperimental Treatment1 Intervention

E-CBSST is the experimental arm in this study.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor

1,120 Previous Clinical Trials

1,521,357 Total Patients Enrolled

27 Trials studying Schizophrenia

5,852 Patients Enrolled for Schizophrenia

Centre for Addiction and Mental HealthOTHER

356 Previous Clinical Trials

81,394 Total Patients Enrolled

58 Trials studying Schizophrenia

4,181 Patients Enrolled for Schizophrenia

Eric Granholm, PhDPrincipal InvestigatorUniversity of California, San Diego

3 Previous Clinical Trials

288 Total Patients Enrolled

3 Trials studying Schizophrenia

288 Patients Enrolled for Schizophrenia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment process currently open for this clinical trial?

"As per clinicaltrials.gov, the current status of this research study is not open for participant recruitment. The trial was initially listed on 2/1/2024 and last revised on the same date. Although this specific trial isn't actively enrolling, there are presently 448 alternative trials seeking participants."

Answered by AI

What is the primary objective of this medical study?

"The primary objective of this investigation is to conduct a Comprehensive Modules Test across various time points: Baseline, End of Executive Function Training (Week 2), Mid-Trial (Week 11), and End-Trial (Week 20). The study also aims to evaluate secondary outcomes including the Social Skills Performance Assessment, which measures social skill proficiency through role-play scenarios with scores ranging from 2-10; the Executive Interview assessing executive function on a scale of 0-50; and the Positive and Negative Syndrome Scale evaluating positive and negative symptoms using a range of ratings that sum up to total scores between 30 to 210."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Optimizing CBSST With Executive Function Training for Schizophrenia

Eric Granholm 2024. "Optimizing CBSST With Executive Function Training for Schizophrenia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06251193.